Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andras Perl

Showing results (21-30 of 149) with videos related to

Pageof 15
Sort By:
Immunometabolism (Cobham, Surrey)|October 31, 2022
Principles behind SLE treatment with <i>N</i>-acetylcysteineSandy Nasr, Andras Perl
Autoimmunity Reviews|October 31, 2021
Therapeutic mTOR blockade in systemic autoimmunity: Implications for antiviral immunity and extension of lifespanChristian Geier, Andras Perl
Methods in Molecular Biology (Clifton, N.J.)|August 31, 2012
The role of endocytic recycling in autoimmunityTiffany Telarico, Andras Perl
Expert Opinion on Pharmacotherapy|June 9, 2020
Management of cardiovascular disease in patients with systemic lupus erythematosusParamarjan Piranavan, Andras Perl
Autoimmunity Reviews|August 30, 2008
Metabolic control of T cell activation and death in SLEDavid Fernandez, Andras Perl
Current Opinion in Rheumatology|January 3, 2020
Metabolic pathways mediate pathogenesis and offer targets for treatment in rheumatic diseasesBrandon Wyman, Andras Perl
Autoimmunity|October 17, 2013
Metabolic control of the epigenome in systemic Lupus erythematosusZachary Oaks, Andras Perl
Ebiomedicine|March 12, 2023
Expanding scope of TEMRA in autoimmunityAndras Perl, Laurence Morel
Current Opinion in Rheumatology|April 4, 2026
Pathogenesis-directed lupus therapeuticsBhavya Poudyal, Andras Perl
Frontiers in Immunology|March 25, 2021
Double-Edged Sword: Interleukin-2 Promotes T Regulatory Cell Differentiation but Also Expands Interleukin-13- and Interferon-γ-Producing CD8<sup>+</sup> T Cells <i>via</i> STAT6-GATA-3 Axis in Systemic Lupus ErythematosusHiroshi Kato, Andras Perl
Pageof 15

Showing results (21-30 of 149) with videos related to

Sort By:
Pageof 15
Immunometabolism (Cobham, Surrey)|October 31, 2022
Principles behind SLE treatment with <i>N</i>-acetylcysteineSandy Nasr, Andras Perl
Autoimmunity Reviews|October 31, 2021
Therapeutic mTOR blockade in systemic autoimmunity: Implications for antiviral immunity and extension of lifespanChristian Geier, Andras Perl
Methods in Molecular Biology (Clifton, N.J.)|August 31, 2012
The role of endocytic recycling in autoimmunityTiffany Telarico, Andras Perl
Expert Opinion on Pharmacotherapy|June 9, 2020
Management of cardiovascular disease in patients with systemic lupus erythematosusParamarjan Piranavan, Andras Perl
Autoimmunity Reviews|August 30, 2008
Metabolic control of T cell activation and death in SLEDavid Fernandez, Andras Perl
Current Opinion in Rheumatology|January 3, 2020
Metabolic pathways mediate pathogenesis and offer targets for treatment in rheumatic diseasesBrandon Wyman, Andras Perl
Autoimmunity|October 17, 2013
Metabolic control of the epigenome in systemic Lupus erythematosusZachary Oaks, Andras Perl
Ebiomedicine|March 12, 2023
Expanding scope of TEMRA in autoimmunityAndras Perl, Laurence Morel
Current Opinion in Rheumatology|April 4, 2026
Pathogenesis-directed lupus therapeuticsBhavya Poudyal, Andras Perl
Frontiers in Immunology|March 25, 2021
Double-Edged Sword: Interleukin-2 Promotes T Regulatory Cell Differentiation but Also Expands Interleukin-13- and Interferon-γ-Producing CD8<sup>+</sup> T Cells <i>via</i> STAT6-GATA-3 Axis in Systemic Lupus ErythematosusHiroshi Kato, Andras Perl
Pageof 15